High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$31.1M
$31,124,887
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
HCA
S
HCA Healthcare, Inc.
McAlevey Michael R
• Officer • EVP & Chief Legal & Admin Off.
Discretionary SellΔOwn -16.1%
2026-02-18
$903,537
|
||||||
| HCA |
HCA Healthcare, Inc.
|
Officer • EVP & Chief Legal & Admin Off.
Discretionary SellΔOwn -16.1%
|
2026-02-18 | $903,537 | S | Form 4 |
|
HCA
S
HCA Healthcare, Inc.
Berres Jennifer
• Officer • SVP & Chief Human Res. Officer
Discretionary SellΔOwn -20.0%
2026-02-11
$4,126,950Largex2
|
||||||
| HCA |
HCA Healthcare, Inc.
|
Officer • SVP & Chief Human Res. Officer
Discretionary SellΔOwn -20.0%
|
2026-02-11 | $4,126,950Largex2 | S | Form 4 |
|
HCA
S
HCA Healthcare, Inc.
Wyatt Christopher F.
• Officer • SVP & Controller
Discretionary Sell
2026-02-11
$2,020,000Large
|
||||||
| HCA |
HCA Healthcare, Inc.
|
Officer • SVP & Controller
Discretionary Sell
|
2026-02-11 | $2,020,000Large | S | Form 4 |
|
HCA
S
HCA Healthcare, Inc.
Cuffe Michael S.
• Officer • EVP and Chief Clinical Officer
Discretionary Sell
2026-02-03
$747,135
|
||||||
| HCA |
HCA Healthcare, Inc.
|
Officer • EVP and Chief Clinical Officer
Discretionary Sell
|
2026-02-03 | $747,135 | S | Form 4 |
| HCA |
HCA Healthcare, Inc.
|
CEO
Discretionary Sell
|
2026-02-03 | $21,483,275MEGAx7 | S | Form 4 |
|
HCA
S
HCA Healthcare, Inc.
McAlevey Michael R
• Officer • EVP & Chief Legal & Admin Off.
Discretionary SellΔOwn -52.7%
2025-11-05
$1,843,991Large
|
||||||
| HCA |
HCA Healthcare, Inc.
|
Officer • EVP & Chief Legal & Admin Off.
Discretionary SellΔOwn -52.7%
|
2025-11-05 | $1,843,991Large | S | Form 4 |